Literature DB >> 7890283

Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy.

T Nishino1, Y Horii, H Shiiki, H Yamamoto, Z Makita, R Bucala, K Dohi.   

Abstract

Numerous studies over the years have implicated advanced glycosylation end products (AGEs) in the pathogenesis of many of the complications of diabetes and normal aging. The recent development of specific antibodies against AGE-modified proteins has facilitated investigations on the formation and tissue distribution of AGEs. We used anti-AGE antibodies to localize AGEs within kidney specimens obtained from both diabetic and nondiabetic individuals. Immunohistochemical staining using anti-AGE antibody showed a high level of AGE accumulation in diabetic and aged vascular intima, particularly along the inner elastic layer of arteries. Positive staining also was observed within nodular and severe diffuse lesions of glomeruli as well as in hyaline deposits of arterioles. These data support a pathogenic role for advanced glycosylation in the renal complications of diabetes and aging.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890283     DOI: 10.1016/0046-8177(95)90063-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

Review 1.  Oxidative stress and diabetic complications.

Authors:  Ferdinando Giacco; Michael Brownlee
Journal:  Circ Res       Date:  2010-10-29       Impact factor: 17.367

2.  Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique - Skin Autofluorescence.

Authors:  Mihaela Oleniuc; Irina Secara; Mihai Onofriescu; Simona Hogas; Luminita Voroneanu; Dimitrie Siriopol; Adrian Covic
Journal:  Maedica (Buchar)       Date:  2011-10

3.  Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology.

Authors:  Kazuho Honda; Chieko Hamada; Masaaki Nakayama; Masanobu Miyazaki; Ali M Sherif; Takashi Harada; Hiroshi Hirano
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 8.237

4.  Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.

Authors:  N Sasaki; R Fukatsu; K Tsuzuki; Y Hayashi; T Yoshida; N Fujii; T Koike; I Wakayama; R Yanagihara; R Garruto; N Amano; Z Makita
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

5.  Combined therapy with metformin and insulin attenuates systemic and hepatic alterations in a model of high-fat diet-/streptozotocin-induced diabetes.

Authors:  Raquel Rangel Silvares; Evelyn Nunes Goulart da Silva Pereira; Edgar Eduardo Ilaquita Flores; Vanessa Estato; Patrícia Alves Reis; Igor José da Silva; Marcelo Pelajo Machado; Hugo Caire de Castro Faria Neto; Eduardo Tibiriça; Anissa Daliry
Journal:  Int J Exp Pathol       Date:  2016-07-06       Impact factor: 1.925

Review 6.  Oxidative stress in diabetes: implications for vascular and other complications.

Authors:  Dario Pitocco; Manfredi Tesauro; Rizzi Alessandro; Giovanni Ghirlanda; Carmine Cardillo
Journal:  Int J Mol Sci       Date:  2013-10-30       Impact factor: 5.923

7.  Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes.

Authors:  Pierre-Jean Saulnier; Kevin M Wheelock; Scott Howell; E Jennifer Weil; Stephanie K Tanamas; William C Knowler; Kevin V Lemley; Michael Mauer; Berne Yee; Robert G Nelson; Paul J Beisswenger
Journal:  Diabetes       Date:  2016-09-08       Impact factor: 9.461

8.  UV Fluorescence-Based Determination of Urinary Advanced Glycation End Products in Patients with Chronic Kidney Disease.

Authors:  Mieke Steenbeke; Sander De Bruyne; Elisabeth Van Aken; Griet Glorieux; Wim Van Biesen; Jonas Himpe; Gilles De Meester; Marijn Speeckaert; Joris Delanghe
Journal:  Diagnostics (Basel)       Date:  2020-01-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.